True Bearing
Diagnostics, Inc.
* Over $100 billion potential savings in the US alone by
reducing unnecessary slowdown of the economy and education due to emerging
pandemics.
• Population Scale Triage Diagnostic: Rapid
diagnostic testing allows identification and quarantine of infected
persons.
True Bearing Diagnostics is developing TruNAv, a novel
blood RNA-based diagnostic test designed for the early detection of pandemics like
COVID19. TruNAv is based on selective capture of immune cells and detecting RNA
transcripts that are highly sensitive to Neutrophil Activation by any pathogen,
making it an ideal test for the early detection of infections.